A CHINESE SUBGROUP ANALYSIS OF THE ASIAN PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF VONOPRAZAN 10 OR 20 MG COMPARED WITH LANSOPRAZOLE 15 MG IN THE MAINTENANCE TREATMENT OF ASIAN PATIENTS WITH EROSIVE ESOPHAGITIS

Yinglian Xiao  1     Jiaming Qian  2     Shutian Zhang  3     Ning Dai  4     Nobuo Funao  5     yuuichi sakurai  6     lu dong     Li Xie     Minhu Chen    
1 The First Affiliated Hospital, Sun Yat-sen University,Guangzhou,China
2 Peking Union Medical College Hospital,Beijing,China
3 Beijing Friendship Hospital, Capital Medical University,Beijing,China
4 Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University,Zhejiang,China
5 Takeda Pharmaceutical Company,Osaka,Japan
6 Takeda Pharmace

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing